Stocksigma LogoStocksigma Logo

Biogen Pharmachem Reports Q2 Results with ₹25.73 Lakh Profit

Biogen Pharmachem Industries posted a net profit of ₹25.73 lakh for the quarter ended 30th Sep'26, turning around from a net loss of ₹49.15 lakh in the

Biogen Pharmachem Reports Q2 Results with ₹25.73 Lakh Profit

Biogen Pharmachem Industries Ltd · Outcome · 03 Nov 2026, 8:42 pm

Biogen Pharmachem Reports Q2 Results with ₹25.73 Lakh Profit Biogen Pharmachem Industries posted a net profit of ₹25.73 lakh for the quarter ended 30th Sep'26, turning around from a net loss of ₹49.15 lakh in the year-ago period and up 16.2% QoQ from ₹22.14 lakh. Core operational revenue remained nil, with total income entirely driven by other income of ₹28.33 lakh versus negative ₹10.49 lakh YoY. Total expenses fell sharply to ₹2.61 lakh from ₹38.67 lakh YoY. For H1 ended 30th Sep'26, net profit reached ₹47.87 lakh compared to ₹85.33 lakh YoY.

Original exchange filing (PDF)

More announcements from Biogen Pharmachem Industries Ltd

All Biogen Pharmachem Industries Ltd announcements